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Abstract: The possibility of introducing a reliable assay for a quick identification and differentiation of
the main species of Mycobacterium tuberculosis complex (MTBC) supports the improvement of efficient
tuberculosis combating strategies worldwide. Commercially available assays are often based on cultured
samples; however, due to the long cultivation time of mycobacteria, results are delayed. Developed
PCR approaches have been published previously, though, when testing intricate veterinary samples,
the complex composition of multiplex qPCRs frequently leads to assay failure. In order to overcome
those limits, a paradigm of a three-reaction high-resolution melting (HRM) assay for the simultaneous
identification and differentiation of the main members of MTBC was established. The assay is based
on single nucleotide polymorphisms within gyrB and gyrA, which have been used as target for the
establishment of two highly specific HRM assays (HRM assays 1 and 2) discriminating M. tuberculosis/
Mycobacterium canetti, Mycobacterium bovis/M. bovis BCG, Mycobacterium caprae/rare M. caprae/M.
bovis ecotypes, Mycobacterium africanum/Mycobacterium orygis/ Mycobacterium pinnipedii/Clade A1,
Mycobacterium microti, and a rare subtype of M. canettii followed by a third HRM assay (HRM assay 3)
allowing a further differentiation of M. bovis, M. bovis BCG, and a rare subtype of M. caprae/M. bovis,
which is considered to be a novel ecotype. High-resolution melting assay 1 is described in a previously
published report. High-resolution melting assay 2 showed 100% correlation of all 39 examined isolates
with the results of a commercial identification kit. 96% of the clinical samples tested demonstrated
concordant results. High-resolution melting assay 3 showed an accordance of 100% with the results of
the commercially available identification kit of all 22 samples analyzed. The proposed strategy of the
three-reaction HRM assay can be used for an accurate differentiation of up to seven groups of MTBC
and potentially to identify a rare subtype of M. canettii either on isolates or on clinical samples.
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HRM	assays	(HRM	assays	1	and	2)	discriminating	M. tuberculosis/ Mycobacterium can-
etti, Mycobacterium bovis/M. bovis	BCG, Mycobacterium caprae/rare M. caprae/M. bovis 
ecotypes, Mycobacterium africanum/Mycobacterium orygis/ Mycobacterium pinnipedii/

















Mycobacterium tuberculosis	 complex	 (MTBC)	 comprises	 the	
closely related species Mycobacterium (M.) tuberculosis,	 M. bovis,	
M. bovis	Bacillus	Calmette	and	Guérin	(BCG),	M. caprae,	M. africanum,	
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M. microti,	M. pinnipedii, M. orygis,	 and	 four	 further	 species	known	
as	animal‐adapted	Clade	A1	(Dassie	bacillus,	M. mungi,	Chimpanzee	
bacillus,	 and	 M. suricattae)	 (Brites	 et	 al.,	 2018).	 Furthermore,	
Mycobacterium canettii is a genetically more diverse and recombino‐
genic	organism	as	observed	earlier	(Fabre	et	al.,	2010),	only	leading	
to	 opportunistic	 human	 infections	 from	 time	 to	 time	 (Boritsch	 et	
al.,	2016;	Supply	et	al.,	2013).	Although	its	similarity	of	the	nucleo‐
tide	codes	to	the	species	of	MBTC,	it	is	not	considered	to	be	part	of	
MTBC	(Brites	et	al.,	2018).	Mycobacterium canettii is mainly limited 
to	the	horn	of	Africa	and	most	of	the	known	strains	were	 isolated	
in	 the	Republic	of	Djibouti	 (Blouin	et	al.,	2014).	Mycobacterium tu-
berculosis	 is	known	to	be	 the	major	 source	of	human	 tuberculosis;	
however,	 numerous	 cases	of	 infection	with	other	members	of	 the	
complex are known. Mycobacterium bovis and more rarely M. caprae 
are	the	causative	agents	for	bovine	tuberculosis,	which	is	recognized	
to	 be	 an	 important	 zoonosis	 responsible	 for	 significant	 economic	
loss	(Rodriguez‐Campos,	Smith,	Boniotti,	&	Aranaz,	2014).	A	recent	
study	 (Loiseau	 et	 al.,	 2019)	 revealed	 two	 rare	M. caprae/M. bovis 
ecotypes	 with	 no	 intrinsic	 pyrazinamide	 (PZA)	 resistance,	 in	 con‐
trast to the common M. bovis	 strains,	 detected	 in	 samples	 from	
Malawi	(Guerra‐Assunção	et	al.,	2015),	Germany	(Friedrich	Loeffler	





with	 the	 attenuated	M. bovis	 strain	 BCG.	 In	 immunocompromised	
children,	 this	procedure	can	cause	a	disease	pattern	similar	 to	 the	





Various	 molecular	 assays	 exist	 to	 differentiate	 species	 within	
MTBC.	 Nevertheless,	 many	 approaches	 have	 several	 limits.	 Most	
of	 the	methods	 as,	 for	 example,	 the	 commercial	GenoType	MTBC	
test	 are	 not	 validated	 for	 use	 on	 clinical	 samples	 (Costa,	 Amaro,	
et	 al.,	 2014;	Kasai,	 Ezaki,	&	Harayama,	 2000;	Niemann,	Harmsen,	
Rüsch‐Gerdes,	&	Richter,	2000;	Pinsky	&	Banaei,	2008;	Pounder	et	
al.,	2010;	Reddington	et	al.,	2012).	Since	Mycobacteria	require	many	
months	 to	 obtain	 considerable	 growth	 in	 culture,	 methods	 based	
on	 cultivated	 isolates	 require	much	 time	 to	determine	 the	 correct	
MTBC	 species.	 Other	 methods	 are	 very	 laborious	 (Kamerbeek	 et	
al.,	 1997),	 require	 expensive	 equipment	 (Jagielski	 et	 al.,	 2014),	 or	
rely	 on	multiplex	 qPCR	 assays	 (Costa,	 Amaro,	 et	 al.,	 2014;	 Halse,	





assays,	 which	 are	 able	 to	 detect	 single	 nucleotide	 polymorphism	
(SNP)	according	to	altered	melting	temperatures	(Tm)	of	dissociating	
PCR	amplicons	(Vossen,	Aten,	Roos,	&	Dunnen,	2009).	A	fluorescent	














bacteria	 (NTM)	 and	 confining	 them	 from	MTBC	 (Issa	 et	 al.,	 2014;	
Khosravi,	Hashemzadeh,	Hashemi	Shahraki,	&	Teimoori,	2017;	Perng	
et	al.,	2012).	Some	studies	combined	HRM	with	multiplex	qPCR	as‐
says	 targeting	 at	 the	 region	 of	 difference	 (RD)	 (Pinsky	 &	 Banaei,	
2008;	Pounder	et	al.,	2010).
We	 have	 previously	 reported	 the	 design	 and	 evaluation	 of	 a	
HRM	assay	(HRM	assay	1)	for	the	identification	and	differentiation	
of	MTBC	into	three	groups	most	relevant	for	veterinarians	(Landolt,	
Stephan,	 &	 Scherrer,	 2019).	 In	 the	 present	 study,	 two	 additional	
HRM	 assays	 (HRM	 assays	 2	 and	 3)	 were	 developed	with	 the	 aim	
to	discern	the	main	members	of	MTBC.	By	combining	HRM	assays	
1	and	2	targeting	six	SNPs	on	the	gyrB	gene,	a	two‐step	paradigm	
was	 obtained,	 distinguishing	M. tuberculosis/M. canettii,	M. canettii 
(rare	subtype),	M. africanum/M. orygis/M. pinnipedii/Clade A1,	M. bo-
vis/M. bovis	BCG,	M. caprae/rare M. caprae/M. bovis	 ecotypes,	 and	
M. microti	in	cultured	isolates	and	clinical	samples.	If	requested,	it	is	
possible	to	further	differentiate	M. bovis,	M. bovis	BCG,	and	one	of	












High‐resolution	 melting	 assay	 3	 was	 validated	 to	 distinguish	 be‐
tween M. bovis and M. bovis	BCG	using	15	M. bovis	 isolates	and	7	
M. bovis	clinical	samples.	Positive	control	samples	(M. microti	ATCC	
19422,	 M. bovis	 BCG	 Pasteur	 ATCC	 35734,	 M. bovis	 BCG	 Tice	
ATCC	27289,	 and	M. tuberculosis	H37Rv)	were	used	 in	each	qPCR	
run.	Clinical	samples	were	received	in	the	Laboratory	of	Veterinary	
Bacteriology,	University	of	Zurich,	between	2013	and	2016.
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2.2 | Culture and DNA extraction
Sample	preparation,	 culture,	 and	DNA	extraction	were	 conducted	
as	described	 in	a	 former	study	 (Ghielmetti	et	al.,	2017).	GenoType	
MTBC	test	(Hain	Lifescience),	spoligotyping	(Ruettger	et	al.,	2012),	
and	 multilocus	 variable	 number	 tandem	 repeat	 analysis	 using	 an	
internationally	established	24‐loci	panel	 (Supply	et	al.,	2006)	were	










rare	ecotypes	of	M. caprae/M. bovis	(ecotypes	I	and	II),	a	rare	M. can-
ettii	 subtype	 (Loiseau	 et	 al.,	 2019)	 and	 the	 animal‐adapted	MTBC	
clades	 (Brites	et	al.,	2018),	 two	additional	SNPs	on	gyrB (base pair 
positions	1,437	and	1,439),	and	one	SNP	on	gyrA (base pair position 
1,359)	were	included	in	the	assay	design	(Figure	1).
2.4 | Primer of HRM assays
Primers	 were	 designed	 based	 on	 alignments	 of	 the	 available	 se‐
quences	of	gyrB and gyrA	from	MTBC	(GenBank	accession	numbers:	
gyrB M. bovis	AB014184.1,	gyrB M. microti	AB014205.1,	gyrB M. tu-
berculosis	X78888.1,	gyrB M. africanum	FR878060.1,	gyrB M. caprae 
CP016401.1,	 gyrA M. bovis	 LT708304.1,	 and	 gyrA M. bovis	 BCG	
Pasteur	AM408590.1).	 The	 designed	 primers	 amplify	 a	 conserved	
107‐base	pair	 (bp)	 fragment	within	gyrB	 comprising	 two	SNPs	and	
gyrA	comprising	one	SNP,	respectively	(Figure	1).	Gene	specificity	of	
all	primers	was	confirmed	by	NCBI	BLAST	searches.	Primers	were	




tem	 (Qiagen)	with	 the	 Type‐it	HRM	PCR	Kit	 (Qiagen).	 The	 qPCRs	
were	 performed	 as	 described	 previously	 (Landolt	 et	 al.,	 2019).	
High‐resolution	 melting	 ramping	 from	 76°C	 to	 93°C	 was	 applied.	
Fluorescence	 data	 were	 measured	 every	 2	 s	 at	 0.1°C	 increments	
generating	 specific	 melting	 curves.	 Reference	 strains	 M. microtii 





analysis	 to	 generate	 normalized	 and	 difference	 plots	 as	 described	
in	a	previous	study	(Landolt	et	al.,	2019).	To	prevent	false‐negative	
results	possibly	deriving	from	inhibition,	clinical	samples	were	ana‐







M. tuberculosis Elephant 3  
M. caprae Cow 7  
M. bovis Cow 15 15
M. microti Cat 8  
M. microti Alpaca 3  
M. microti Llama 2  
M. microti Wild	boar	(Spain) 1  
Clinical	samples	(n	=	23)  
M. tuberculosis Elephant 2  
M. caprae Cow 4  
M. bovis Cow 7 7
M. microti Cat 5  
M. microti Alpaca 3  





TA B L E  1  MTBC‐positive	samples	used	
for	the	development	of	the	HRM	assays	
2 and 3
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To	 investigate	 the	 intra‐	 and	 interassay	 variability	 of	 the	Tm,	
illustrating	 the	 repeatability	 of	 the	 developed	 HRM	 assays,	 a	
randomly	 chosen	 subset	 of	 22	 cultured	 isolates	 and	 18	 clinical	
specimens	for	HRM	assays	2	and	9	cultured	isolates	and	7	clinical	




To	 check	 for	 possible	 nonspecific	 signals	 of	 HRM	 assays	 2	 and	









the clinical isolate M. bovis	ZH20665	in	an	analogous	manner	by	ana‐
lyzing	10‐fold	DNA	dilution	series.	Based	on	an	estimated	genome	
size	of	4.4	Mb	for	members	of	MTBC,	1	GE	correlates	with	a	DNA	
quantity	 of	 4.8	 fg.	 The	 slope	 of	 the	 resulting	 standard	 curve	 cor‐
responded	to	the	amplification	efficiency	of	each	tested	strain.	The	
F I G U R E  1  Differentiation	of	MTBC	based	on	eight	different	single	nucleotide	polymorphisms	(SNPs).	Numbers	represent	the	position	of	
the	SNP	in	relation	to	the	start	codon	of	gyrB and gyrA,	respectively.	(a)	Six	SNPs	on	gyrB	are	represented.	HRM	assay	1	(Landolt	et	al.,	2019)	
allows the distinction between M. tuberculosis/M. canettii/M. africanum/M. orygis/M. pinnipedii/Clade	A1,	M. microti/M. canettii	(rare	subtype)	
and M. bovis/M. bovis	BCG/M. caprae/rare M. caprae/M. bovis	ecotypes.	HRM	assay	2	can	differentiate	between	M. tuberculosis/M. canettii,	
M. canettii	(rare	subtype),	M. africanum/M. orygis/M. pinnipedii/Clade	A1/M. microti/M. caprae/rare M. caprae/M. bovis	ecotypes,	and	
M. bovis/M. bovis	BCG.	Combining	the	results	of	HRM	assays	1	and	2,	six	groups	can	be	distinguished:	M. canettii	(rare	subtype),	
M. tuberculosis/M. canettii, M. africanum/M. orygis/M. pinnipedii/Clade	A1, M. microti, M. caprae/rare M. caprae/M. bovis	ecotypes,	and	
M. bovis/M. bovis	BCG.	(b)	Two	SNPs	on	positions	1,323	and	1,359	of	gyrA	are	illustrated	indicating	the	differentiation	between	M. bovis,	
M. bovis	BCG,	and	rare	M. caprae/M. bovis	ecotype	I.	*Rare	subtype,	highly	recombinogenic	strain,	intrinsic	pyrazinamide	(PZA)	resistance.	
**Intrinsic	PZA	resistance.	***No	intrinsic	PZA	resistance.	****Intrinsic	PZA	and	cycloserine	resistance
TA B L E  2  Primers	used	for	the	three‐reaction	HRM	paradigm























All	 cultured	 isolates	 tested	 were	 amplified	 successfully	 yielding	











High‐resolution	 melting	 assay	 2	 differentiates	 three	 groups,	
namely M. tuberculosis,	M. microti/M. caprae,	 and	M. bovis/M. bovis 
BCG.	 The	 obtained	 intra‐assay	 coefficients	 of	 variation	 (CVs)	 and	
the	interassay	CVs	were	ranging	between	0.01%–0.04%	and	0.11%–
0.17%,	respectively	(Table	3,	Table	A3),	demonstrating	highly	repro‐
ducible	 and	 robust	 assays.	 Species	 identification	 results	 of	 all	 39	
(100%)	tested	cultured	isolates	were	in	accordance	with	the	species	
classification	of	GenoType	MTBC	test	(Hain	Lifescience)	results.
High‐resolution	 melting	 assay	 3	 differentiates	 M. bovis	 from	
M. bovis	BCG.	The	 intra‐assay	CVs	and	the	 interassay	CVs	yielded	
Tm	 values	 ranging	 between	 0.01%–0.03%	 and	 0.03%–0.04%,	 re‐
spectively	 (Table	 4,	 Table	 A4).	 Species	 identification	 results	 of	
all	 15	 (100%)	 tested	cultured	 isolates	were	 in	 agreement	with	 the	
GenoType	MTBC	test	(Hain	Lifescience)	results.
TA B L E  3   Intra‐	and	interassay	variability	of	HRM	assay	2	of	cultured	samples
 
Run 1 Run 2 Run 3 Interassay
Tm CV% Tm CV% Tm CV% Tm CV%
M. tuberculosis 
H37Rv




82.62  82.77  82.70  82.7 0.09
M. microti	ATCC	
19422
83.13  83.25  83.28  83.22 0.10
M. tuberculosis 
(n	=	3)
83.56	±	0.04 0.01 83.84	±	0.04 0.02 83.66	±	0.06 0.04 83.70	±	0.18 0.17
M. bovis (n	=	6) 82.70	±	0.10 0.04 82.93	±	0.08 0.03 82.74	±	0.06 0.02 82.80	±	0.20 0.14
M. caprae (n	=	6) 83.12	±	0.09 0.03 83.27	±	0.09 0.02 83.23	±	0.06 0.02 83.19	±	0.16 0.11
M. microti (n	=	7) 83.10	±	0.08 0.02 83.34	±	0.09 0.04 83.29	±	0.04 0.01 83.23	±	0.21 0.14
Note: Mean	values	and	standard	deviation	of	melting	temperatures	(Tm)	of	a	randomly	chosen	subset	of	cultured	samples	are	listed.	Corresponding	
coefficients	of	variation	(CV)	in	%	are	indicated	for	each	MTBC	species	tested.
TA B L E  4   Intra‐	and	interassay	variability	of	HRM	assay	3	of	cultured	samples
 
Run 1 Run 2 Run 3 Interassay
Tm CV% Tm CV% Tm CV% Tm CV%
M. tuberculosis 
H37Rv
86.82  86.82  86.85  86.83 0.02
M. microti	ATCC	
19422




86.42  86.38  86.42  86.41 0.03
M. bovis (n	=	7) 86.83	±	0.50 0.01 86.83	±	0.08 0.02 86.83	±	0.10 0.03 86.83	±	0.10 0.03
M. bovis	BCG	(n	=	2) 86.39	±	0.06 0.03 86.41	±	0.03 0.03 86.45	±	0.03 0.03 86.41	±	0.08 0.04
Note: Mean	values	and	standard	deviation	of	melting	temperatures	(Tm)	of	a	randomly	chosen	subset	of	cultured	samples	are	listed.	Corresponding	
coefficients	of	variation	(CV)	in	%	are	indicated	for	each	MTBC	species	tested.
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3.2 | HRM of clinical samples
For	 22/23	 (96%)	 clinical	 samples	 tested	 in	 HRM	 assay	 2,	 ob‐
tained	 normalized	 and	 difference	 plots	 (Figure	 4b,c)	 showed	
the	appearance	of	 three	distinct	groups,	namely	M. tuberculosis,	
M. microti/M. caprae,	 and	M. bovis/M. bovis	 BCG	 in	 accordance	
with	the	results	of	GenoType	MTBC	test	(Hain	Lifescience).	One	
sample	revealed	significantly	lower	Tm	values	compared	with	the	
other	 results.	 This	 clinical	 sample	 (samples	 17–1,063),	 however,	
has	not	yet	been	successfully	cultured	and	 is	 in	 the	progress	of	
further	 investigations.	 High‐resolution	 melting	 assay	 3	 showed	
a	clear	distinction	of	all	cultured	 isolates	as	well	as	directly	 iso‐
lated	 clinical	 samples	 of	 M. bovis	 from	 M. bovis	 BCG	 in	 100%	




High‐resolution	 melting	 assay	 3	 showed	 intra‐assay	 CVs	 be‐
tween	0.01%	and	0.02%	and	 an	 interassay	CV	of	 0.04%	 (Table	6,	
Table	A4).
3.3 | Specificity
Forty‐one	NTM	and	N. paucivorans,	E. coli,	 and	S. suis were tested 
for	 specificity	 of	 HRM	 assay	 2	 resulting	 in	 no	 melting	 curves	 or	
melting	 curves	with	entirely	different	Tm in respect to Tm deriving 










in relation to M. bovis	BCG	Pasteur	ATCC	
35734
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from	samples	of	MTBC.	In	HRM	assay	3,	some	NTM	showed	similar	
curves	and	Tm	values.	Therefore,	HRM	assay	3	is	recommended	to	be	









template	DNA	in	the	qPCR,	for	M. tuberculosis, M. caprae, M. microti,	
and M. bovis	(Table	7).	The	LOD	of	HRM	assay	3	was	100	GE	for	both	
M. bovis and M. bovis	BCG	(Table	8).
4  | DISCUSSION
In	 the	 present	 study,	 the	 establishment	 of	 a	 three‐reaction	 HRM	
paradigm	in	the	form	of	three	HRM	assays	is	described,	which	can	
rapidly	differentiate	the	main	species	of	MTBC.	M. microti, M. tuber-
culosis, M. caprae, M. bovis,	and	M. bovis	BCG	were	demonstrated	to	
undoubtedly	and	consistently	be	differentiated	from	each	other	by	
distinctive	 difference	 plots	 (Figures	 2c,	 3c,	 and	 4c).	 Based	 on	 the	







in	pink,	cultured	samples	of	M. bovis in 


























question	raised.	In	case	of	a	probable	detection	of	M. orygis strains 
















in relation to M. bovis	BCG	Pasteur	ATCC	
35734








differentiation	of	M. caprae/M. bovis	ecotype	II	from	M. caprae has no 
advantage	in	respect	to	the	choice	of	antibiotic	treatment,	because	
both	strain	types	are	not	intrinsically	resistant	to	PZA.
By	a	 stepwise	 combination	of	 three	 independent	HRM	assays,	
it	is	possible	to	differentiate	the	species	of	MTBC	firstly	into	three	
groups	 (M. microti/M. canettii	 (rare	 subtype), M. tuberculosis/M. af-
ricanum/M. orygis/M. pinnipedii/Clade	 A1,	 and	 M. caprae/M. bo-
vis/M. bovis	BCG/rare	M. caprae/M. bovis	ecotypes),	secondly	into	six	
groups	 (M. microti, M. tuberculosis/M. canettii, M. canettii	 (rare	sub‐
type),	M. africanum/M. orygis/M. pinnipedi/Clade	A1,	M. caprae/rare 
M. caprae/M. bovis	ecotypes, and M. bovis/M. bovis	BCG),	and	finally	
on gyrA, M. bovis	BCG,	M. bovis,	and	rare	M. caprae/M. bovis ecotype 
I	can	further	be	separated	leading	to	a	clear	differentiation	into	the	
main	 human‐	 and	 veterinary‐associated	MTBC	 species	 (Figure	 5).	
The	 three	HRM	 assays	 can	 be	 performed	 either	 consecutively	 or	
in	parallel	 since	 the	qPCR	conditions	are	equal.	The	 interpretation	




Tm	 ranges	 deriving	 from	HRM	 assays	 are	 partially	 overlapping	
(Tables	3‒6).	Therefore,	based	solely	on	Tm it is not possible to clearly 
differentiate	 the	 members	 of	 MTBC.	 However,	 by	 transforming	
melting	curves	into	normalized	and	difference	plots	using	algorithms	
of	the	Rotor‐Gene	Q	Software	2.3.1	(Qiagen),	the	members	of	MTBC	
can	 be	 separated	 into	 distinct	 groups	 (Figures	 2‒4).	 Thereby,	 the	





TA B L E  5   Intra‐	and	interassay	variability	of	HRM	assay	2	of	clinical	specimens
 
Run 1 Run 2 Run 3 Interassay
Tm CV% Tm CV% Tm CV% Tm CV%
M. tuberculosis 
H37Rv




82.82  82.73  82.62  82.72 0.12
M. microti	ATCC	
19422
83.30  83.25  83.08  83.21 0.14
M. tuberculosis 
(n	=	2)
83.71	±	0.13 0.03 83.60	±	0.10 0.03 83.52	±	0.09 0.03 83.63	±	0.20 0.12
M. bovis (n	=	6) 82.97	±	0.10 0.04 82.82	±	0.07 0.02 82.70	±	0.10 0.03 82.84	±	0.24 0.19
M. caprae (n	=	4) 83.24	±	0.14 0.02 83.11	±	0.16 0.02 82.97	±	0.12 0.03 83.11	±	0.26 0.15
M. microti (n	=	6) 83.29	±	0.09 0.02 83.19	±	0.09 0.03 83.00	±	0.10 0.04 83.14	±	0.24 0.16
Note: Mean	values	and	standard	deviation	of	melting	temperatures	(Tm)	of	a	randomly	chosen	subset	of	clinical	specimen	are	listed.	Corresponding	
coefficients	of	variation	(CV)	in	%	are	indicated	for	each	MTBC	species	tested.
TA B L E  6   Intra‐	and	interassay	variability	of	HRM	assay	3	of	clinical	specimens
 
Run 1 Run 2 Run 3 Interassay
Tm CV% Tm CV% Tm CV% Tm CV%
M. tuberculosis 
H37Rv
86.82  86.82  86.85  86.83 0.02
M. microti	ATCC	
19422




86.45  86.42  86.47  86.41 0.03
M. bovis (n	=	7) 86.86	±	0.04 0.01 86.84	±	0.07 0.02 86.88	±	0.08 0.02 86.86	±	0.09 0.04
Note: Mean	values	and	standard	deviation	of	melting	temperatures	(Tm)	of	a	randomly	chosen	subset	of	clinical	specimen	are	listed.	Corresponding	
coefficients	of	variation	(CV)	in	%	are	indicated	for	each	MTBC	species	tested.







finding	were	not	 successful	 yet.	Although	all	 remaining	22	clinical	
samples	deriving	from	lymph	nodes,	lung,	or	liver	tissues	showed	an	
unambiguous	and	correct	result	 (Table	A1),	 it	 is	 important	to	men‐
tion	that	samples	containing	very	little	amount	of	target	DNA	mate‐
rial (as obtained in two tested M. caprae samples and one M. microti 






Summarizing	 the	 obtained	 data,	 both	 HRM	 assays	 2	 and	 3	
showed	 a	 very	 good	 reproducibility	 with	 small	 variations	 of	 Tm,	
which	 is	 demonstrated	 in	 very	 low	values	of	 intra‐	 and	 interassay	
CVs.	Since	HRM	assays	1	and	2	are	proven	to	be	100%	specific,	they	
can	be	used	unambiguously	for	the	identification	and	differentiation	
of	MTBC.	Moreover,	 the	 assays	 yielded	 PCR	 efficiencies	 of	more	







The	 developed	 three‐reaction	 HRM	 paradigm	 is	 a	 quick,	 sensi‐
tive,	 and	 specific	 assay	 for	 differentiation	 of	MTBC	 between	 the	
main	 species	 highly	 relevant	 in	 human	 and	 veterinary	 diagnostics	
namely M. tuberculosis/M. canettii, M. canettii	 (rare	subtype),	M. afr
icanum/M. orygis/M. pinnipedii/Clade A1,	M. microti, M. caprae/rare 
M. caprae/M. bovis	 ecotype	 II, M. bovis,	M. bovis	BCG,	and	 rare	M. 
caprae/M. bovis	ecotype	I	extracted	from	clinical	samples	and	from	
TA B L E  7  Limit	of	detection	(LOD)	of	the	qPCR	of	HRM	assay	2




































































and the clinical specimen M. bovis	ZH	20665.	Bold	represents	the	de‐
termined	LOD	for	the	lowest	dilution	of	which	the	acceptance	criteria	
(standard	deviation	<	0.5	and	Ct	value	<	38)	were	fulfilled.




to	 have	 early	 knowledge	 of	 transmission	 of	 tuberculosis	 for	 con‐
sequently	 choosing	 an	 appropriate	 drug	 therapy	 for	 humans	 or	 a	
proper eradication strategy when dealing with veterinary samples. 
Tuberculosis	 surveillance	 policies	 and	 public	 health	 management	
depend	 on	 powerful	 and	 affordable	 diagnostic	 tools	 such	 as	 this	
paradigm	of	a	three‐reaction	HRM	assay,	which	could	be	easily	im‐
plemented in laboratories worldwide.
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APPENDIX A
TA B L E  A 1  MTBC‐positive	isolates	used	for	the	development	of	the	high‐resolution	melting	(HRM)	assays	2	and	3
Sample Species Origin Specimen Culture? Clinical specimen?
M. bovis	(15)
20175 M. bovis Cow Lung Cultured Not	available
20482 M. bovis Cow Lung,	lymph	node	pool Cultured Not	available
20531 M. bovis Cow Lymph	node	pool Cultured Not	available
20593 M. bovis Cow Lymph	node	pool Cultured Clinical	specimen
20594 M. bovis Cow Lymph	node	pool Cultured Clinical	specimen
20596 M. bovis Cow Lymph	node	pool Cultured Clinical	specimen
20597 M. bovis Cow Lymph	node	pool Cultured Not	available
20599 M. bovis Cow Lymph	node	pool Cultured Not	available
20600 M. bovis Cow Lymph	node	pool Cultured Clinical	specimen
20606 M. bovis Cow Lymph	node	pool Cultured Clinical	specimen
20608 M. bovis Cow Lymph	node	pool Cultured Clinical	specimen
20609 M. bovis Cow Lymph	node	pool Cultured Clinical	specimen
20665 M. bovis Cow Lymph	node	pool Cultured Not	available
22539 M. bovis Cow Lymph	node Cultured Not	available
22667 M. bovis Cow Lymph	node Cultured Not	available
M. caprae	(7)
14‐13 M. caprae Cow Lymph	node Cultured Not	available
22914 M. caprae Cow Lymph	node	pool Cultured Clinical	specimen
22971 M. caprae Cow Lymph	node	pool Cultured Clinical	specimen
22848 M. caprae Cow Liver,	lung,	lymph	node	pool Cultured Clinical	specimen
22966 M. caprae Cow Lymph	node	pool Cultured Not	available
13‐450 M. caprae Cow Lymph	node Cultured Not	available
13‐162 M. caprae Cow Lymph	node Cultured Clinical	specimen
M. microti	(15)
22928 M. microti Cat Lung,	lymph	node	pool Cultured Clinical	specimen
15‐1765 M. microti Cat Lung Cultured Clinical	specimen
15‐342 M. microti Alpaca Lymph	node Cultured Clinical	specimen
14‐58 M. microti Cat Lung Cultured Clinical	specimen
14‐690 M. microti Alpaca Liver Cultured Clinical	specimen
17‐2287 M. microti Alpaca Spleen Cultured Not	available
15817 M. microti Lama Lymph	node Cultured Clinical	specimen
15‐1955 M. microti Cat Lymph	node Cultured Clinical	specimen
16‐2156 M. microti Cat Bronchoalveolar	lavage Cultured Not	available
1522744 M. microti Cat Lung,	lymph	node	pool Cultured Not	available
16‐1347 M. microti Cat Lung Cultured Not	available
17‐1084 M. microti Cat Lymph	node,	skin Cultured Clinical	specimen
17‐1063 M. microti Alpaca Lymph	node,	lung,	heart,	liver,	
cervical vertebra
Culture	ongoing Clinical	specimen
17‐549 M. microti Lama Liver Cultured Clinical	specimen
MI16 M. microti Wildboar	Spain Unknown Cultured Not	available
M. tuberculosis	(4)
15‐961‐2 M. tuberculosis Elephant 1 Lung Cultured Clinical	specimen
15‐961‐1 M. tuberculosis Elephant 1 Pharyngeal	swab Not	cultivated Clinical	specimen
15‐1115‐2 M. tuberculosis Elephant 2 Lung Cultured Not	available
15‐1221‐1 M. tuberculosis Elephant 3 Lung Cultured Not	available
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Species No. of isolates Species No. of isolates
M. abscessus sp. 2 M. malmoense 1
M. avium	subsp.	avium 2 M. marinum 1
M. avium	subsp. 
hominissuis
32 M. monacense 3
M. avium	subsp.	
paratuberculosis
1 M. nebraskense 1
M. avium	subsp.	
silvaticum
1 M. neoaurum 5
M. bourgelatii 1 M. nonchromogenicum 7
M. celatum 1 M. palustre 1
M. chelonae	subsp.	
chelonae
1 M. parafortuitum 2
M. chimaera/intracellulare
/youngonense
1 M. paragordonae 6
M. chitae 1 M. peregrinum 2
M. elephantis 1 M. persicum 2
M. engbaekii 1 M. phlei 3
M. europaeum 1 M. scrofulaceum 1
M. fortuitum/porcinum 1 M. simiae 1
M. goodii 1 M. smegmatis 1
M. gordonae 2 M. szulgai 1
M. hassiacum 1 M. terrae 1
M. interjectum/paraense 1 M. vaccae 4
M. intermedium 1 M. xenopi 5
M. intracellulare 3 Nocardia paucivorans 1
M. kansasii 10 Escherichia coli 1
M. lymphaticum 1 Streptococcus suis 1
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TA B L E  A 3  Raw	data	set	and	statistical	parameters	generated	from	the	intra‐	and	interassay	variability	of	high‐resolution	melting	 
(HRM)	assay	2	using	a	randomly	chosen	subset	of	22	cultured	samples
Isolate Run 1 Run 2 Run 3 Inter‐Assay









CV% Ct Tm Mean Tm SD CV% Intra‐assay CV% Mean Tm SD CV% Inter‐assay CV%
M. microti ATCC	19422  20.65 83.13     20.87 83.25     19.74 83.28     83.22 0.08 0.10  
M. bovis	BCG	
Pasteur
ATCC	35734  24.67 82.62     24.82 82.77     23.57 82.70     82.70 0.08 0.09  
M. tuberculosis H37RV  22.41 83.55     22.44 83.75     20.97 83.60     83.63 0.10 0.12  
M. tuberculosis 15‐961	2B Elephant 14.87 83.60 83.58 0.02 0.02  15.11 83.80 83.80 0.00 0.00  14.01 83.70 83.69 0.02 0.02  83.69 0.11 0.13  
14.95 83.58     15.13 83.80     14.05 83.70         
14.96 83.57     15.14 83.80     13.94 83.67         
M. tuberculosis 15‐1115‐2 Elephant 16.34 83.55 83.54 0.01 0.01  16.69 83.87 83.86 0.03 0.03  15.32 83.63 83.65 0.03 0.03  83.69 0.16 0.19  
16.71 83.55     16.65 83.83     15.47 83.65         
16.73 83.53     16.75 83.88     15.46 83.68         
M. tuberculosis 15‐1221‐1 Elephant 19.59 83.53 83.53 0.01 0.01 0.01 19.98 83.87 83.83 0.04 0.04 0.02 18.45 83.60 83.67 0.06 0.07 0.04 83.68 0.15 0.18 0.17
19.80 83.52     20.02 83.83     18.45 83.68         
19.77 83.53     19.75 83.80     18.47 83.72         
M. caprae 229171 Cow 20.74 83.05 83.05 0.00 0.00  21.20 83.23 83.24 0.01 0.01  19.79 83.23 83.23 0.02 0.02  83.17 0.11 0.13  
37.30      21.09 83.25     19.76 83.22         
21.07 83.05     21.28 83.23     19.55 83.25         
M. caprae 22914 Cow 20.60 83.10 83.12 0.03 0.03  20.97 83.30 83.26 0.04 0.04  19.52 83.27 83.25 0.02 0.02  83.21 0.08 0.10  
20.68 83.10     21.02 83.25     19.59 83.25         
20.71 83.15     20.79 83.23     19.48 83.23         
M. caprae 22848 Cow 22.93 83.07 83.04 0.02 0.03  23.24 83.20 83.19 0.01 0.01  21.68 83.23 83.20 0.03 0.04  83.14 0.09 0.10  
22.94 83.03     23.20 83.18     21.77 83.20         
22.90 83.03     23.34 83.18     21.53 83.17         
M. caprae 22966 Cow 19.89 83.13 83.15 0.02 0.02  20.04 83.35 83.33 0.04 0.05  18.60 83.25 83.26 0.02 0.02  83.25 0.09 0.11  
19.84 83.15     19.97 83.35     18.46 83.25         
19.81 83.17     20.04 83.28     18.84 83.28         
M. caprae 13‐450 Cow 18.04 83.20 83.16 0.04 0.04  18.23 83.30 83.31 0.02 0.02  17.00 83.28 83.28 0.01 0.01  83.25 0.08 0.09  
18.04 83.13     18.10 83.33     16.99 83.28         
18.13 83.15     18.21 83.30     16.93 83.27         
M. caprae 13‐162 Cow 22.08 83.13 83.10 0.03 0.03 0.03 22.43 83.23 83.24 0.01 0.01 0.03 20.91 83.25 83.26 0.01 0.01 0.02 83.20 0.08 0.10 0.11
21.93 83.10     22.23 83.25     20.75 83.25         
22.01 83.08     22.33 83.23     20.87 83.27         
M. bovis 20593 Cow 26.50 82.65 82.64 0.01 0.01  27.13 82.88 82.93 0.06 0.08  25.69 82.68 82.69 0.01 0.01  82.75 0.15 0.18  
24.89 82.65     23.85 83.00     24.93 82.70         
25.63 82.63     24.38 82.90     25.46 82.70         
M. bovis 20594 Cow 25.56 82.60 82.61 0.02 0.02  26.03 82.88 82.88 0.03 0.03  24.80 82.72 82.71 0.02 0.03  82.73 0.14 0.16  
24.81 82.60     25.75 82.85     24.77 82.72         
25.43 82.63     25.79 82.90     23.95 82.68         
M. bovis 20175 Cow 18.77 82.80 82.74 0.05 0.06  18.90 82.98 82.93 0.07 0.09  17.68 82.80 82.78 0.03 0.03  82.82 0.10 0.12  
18.80 82.70     18.92 82.97     17.53 82.80         
18.81 82.73     18.94 82.85     17.66 82.75         
M. bovis 20596 Cow 21.91 82.67 82.67 0.08 0.09  22.37 82.95 82.94 0.01 0.01  21.14 82.80 82.76 0.04 0.04  82.79 0.14 0.17  
22.42 82.75     22.47 82.93     20.81 82.75         
22.56 82.60     22.43 82.95     21.01 82.73         
M. bovis 22667 Cow 19.91 82.80 82.80 0.00 0.00  20.04 82.93 82.92 0.01 0.01  18.95 82.78 82.78 0.01 0.01  82.83 0.08 0.10  
19.84 82.80     20.05 82.92     18.79 82.77         
19.81 82.80     20.05 82.92     19.09 82.78         
(Continues)
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TA B L E  A 3  Raw	data	set	and	statistical	parameters	generated	from	the	intra‐	and	interassay	variability	of	high‐resolution	melting	 
(HRM)	assay	2	using	a	randomly	chosen	subset	of	22	cultured	samples
Isolate Run 1 Run 2 Run 3 Inter‐Assay









CV% Ct Tm Mean Tm SD CV% Intra‐assay CV% Mean Tm SD CV% Inter‐assay CV%
M. microti ATCC	19422  20.65 83.13     20.87 83.25     19.74 83.28     83.22 0.08 0.10  
M. bovis	BCG	
Pasteur
ATCC	35734  24.67 82.62     24.82 82.77     23.57 82.70     82.70 0.08 0.09  
M. tuberculosis H37RV  22.41 83.55     22.44 83.75     20.97 83.60     83.63 0.10 0.12  
M. tuberculosis 15‐961	2B Elephant 14.87 83.60 83.58 0.02 0.02  15.11 83.80 83.80 0.00 0.00  14.01 83.70 83.69 0.02 0.02  83.69 0.11 0.13  
14.95 83.58     15.13 83.80     14.05 83.70         
14.96 83.57     15.14 83.80     13.94 83.67         
M. tuberculosis 15‐1115‐2 Elephant 16.34 83.55 83.54 0.01 0.01  16.69 83.87 83.86 0.03 0.03  15.32 83.63 83.65 0.03 0.03  83.69 0.16 0.19  
16.71 83.55     16.65 83.83     15.47 83.65         
16.73 83.53     16.75 83.88     15.46 83.68         
M. tuberculosis 15‐1221‐1 Elephant 19.59 83.53 83.53 0.01 0.01 0.01 19.98 83.87 83.83 0.04 0.04 0.02 18.45 83.60 83.67 0.06 0.07 0.04 83.68 0.15 0.18 0.17
19.80 83.52     20.02 83.83     18.45 83.68         
19.77 83.53     19.75 83.80     18.47 83.72         
M. caprae 229171 Cow 20.74 83.05 83.05 0.00 0.00  21.20 83.23 83.24 0.01 0.01  19.79 83.23 83.23 0.02 0.02  83.17 0.11 0.13  
37.30      21.09 83.25     19.76 83.22         
21.07 83.05     21.28 83.23     19.55 83.25         
M. caprae 22914 Cow 20.60 83.10 83.12 0.03 0.03  20.97 83.30 83.26 0.04 0.04  19.52 83.27 83.25 0.02 0.02  83.21 0.08 0.10  
20.68 83.10     21.02 83.25     19.59 83.25         
20.71 83.15     20.79 83.23     19.48 83.23         
M. caprae 22848 Cow 22.93 83.07 83.04 0.02 0.03  23.24 83.20 83.19 0.01 0.01  21.68 83.23 83.20 0.03 0.04  83.14 0.09 0.10  
22.94 83.03     23.20 83.18     21.77 83.20         
22.90 83.03     23.34 83.18     21.53 83.17         
M. caprae 22966 Cow 19.89 83.13 83.15 0.02 0.02  20.04 83.35 83.33 0.04 0.05  18.60 83.25 83.26 0.02 0.02  83.25 0.09 0.11  
19.84 83.15     19.97 83.35     18.46 83.25         
19.81 83.17     20.04 83.28     18.84 83.28         
M. caprae 13‐450 Cow 18.04 83.20 83.16 0.04 0.04  18.23 83.30 83.31 0.02 0.02  17.00 83.28 83.28 0.01 0.01  83.25 0.08 0.09  
18.04 83.13     18.10 83.33     16.99 83.28         
18.13 83.15     18.21 83.30     16.93 83.27         
M. caprae 13‐162 Cow 22.08 83.13 83.10 0.03 0.03 0.03 22.43 83.23 83.24 0.01 0.01 0.03 20.91 83.25 83.26 0.01 0.01 0.02 83.20 0.08 0.10 0.11
21.93 83.10     22.23 83.25     20.75 83.25         
22.01 83.08     22.33 83.23     20.87 83.27         
M. bovis 20593 Cow 26.50 82.65 82.64 0.01 0.01  27.13 82.88 82.93 0.06 0.08  25.69 82.68 82.69 0.01 0.01  82.75 0.15 0.18  
24.89 82.65     23.85 83.00     24.93 82.70         
25.63 82.63     24.38 82.90     25.46 82.70         
M. bovis 20594 Cow 25.56 82.60 82.61 0.02 0.02  26.03 82.88 82.88 0.03 0.03  24.80 82.72 82.71 0.02 0.03  82.73 0.14 0.16  
24.81 82.60     25.75 82.85     24.77 82.72         
25.43 82.63     25.79 82.90     23.95 82.68         
M. bovis 20175 Cow 18.77 82.80 82.74 0.05 0.06  18.90 82.98 82.93 0.07 0.09  17.68 82.80 82.78 0.03 0.03  82.82 0.10 0.12  
18.80 82.70     18.92 82.97     17.53 82.80         
18.81 82.73     18.94 82.85     17.66 82.75         
M. bovis 20596 Cow 21.91 82.67 82.67 0.08 0.09  22.37 82.95 82.94 0.01 0.01  21.14 82.80 82.76 0.04 0.04  82.79 0.14 0.17  
22.42 82.75     22.47 82.93     20.81 82.75         
22.56 82.60     22.43 82.95     21.01 82.73         
M. bovis 22667 Cow 19.91 82.80 82.80 0.00 0.00  20.04 82.93 82.92 0.01 0.01  18.95 82.78 82.78 0.01 0.01  82.83 0.08 0.10  
19.84 82.80     20.05 82.92     18.79 82.77         
19.81 82.80     20.05 82.92     19.09 82.78         
(Continues)
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CV% Ct Tm Mean Tm SD CV% Intra‐assay CV% Mean Tm SD CV% Inter‐assay CV%
M. bovis 22539 Cow 21.42 82.73 82.76 0.04 0.04 0.04 21.80 82.92 82.92 0.00 0.00 0.04 20.49 82.77 82.76 0.01 0.01 0.02 82.81 0.09 0.11 0.14
21.55 82.75     21.44 82.92     20.44 82.75         
21.38 82.80     21.60 82.92     20.52 82.75         
M. microti 22928 Cat 16.90 83.17 83.17 0.02 0.02  17.13 83.40 83.42 0.02 0.02  16.01 83.30 83.31 0.01 0.01  83.30 0.13 0.15  
16.93 83.18     17.13 83.43     15.89 83.30         
17.01 83.15     17.08 83.43     16.13 83.32         
M. microti 15‐1765 Cat 21.77 83.18 83.16 0.03 0.03  22.21 83.32 83.30 0.02 0.02  20.79 83.28 83.28 0.02 0.02  83.25 0.08 0.09  
21.44 83.17     21.93 83.30     19.99 83.27         
21.78 83.13     22.05 83.28     20.59 83.30         
M. microti 14‐58 Cat 24.40 83.02 83.02 0.01 0.01  24.39 83.28 83.27 0.02 0.02  23.44 83.28 83.28 0.02 0.02  83.19 0.15 0.18  
24.39 83.02     24.64 83.28     23.18 83.30         
24.31 83.03     24.43 83.25     23.45 83.27         
M. microti 14‐690 Alpaca 15.10 83.05 83.05 0.03 0.03  15.33 83.30 83.29 0.01 0.01  14.28 83.30 83.29 0.01 0.01  83.21 0.14 0.17  
15.13 83.07     15.27 83.28     14.20 83.30         
15.21 83.02     15.29 83.30     14.24 83.28         
M. microti 16‐2156 Cat 23.07 83.07 83.08 0.02 0.02  23.48 83.30 83.31 0.01 0.01  22.32 83.27 83.27 0.00 0.00  83.22 0.12 0.14  
23.49 83.08     23.60 83.30     22.17 83.27         
23.49 83.10     23.57 83.32     22.01 83.27         
M. microti 1522744 Cat 22.79 83.12 83.09 0.03 0.03  22.89 83.33 83.29 0.03 0.04  21.82 83.27 83.26 0.01 0.01  83.21 0.11 0.13  
22.67 83.07     22.97 83.27     21.74 83.27         
22.68 83.08     22.94 83.27     21.49 83.25         
M. microti 16‐1347 Cat 18.92 83.13 83.15 0.03 0.03 0.02 19.20 83.30 83.27 0.03 0.03 0.02 17.52 83.30 83.30 0.00 0.00 0.01 83.24 0.08 0.10 0.14
18.94 83.13     18.99 83.25     17.21 83.30         
18.87 83.18     18.86 83.25     17.32 83.30         
TA B L E  A 3   (Continued)
TA B L E  A 4  Raw	data	set	and	statistical	parameters	generated	from	the	intra‐	and	interassay	variability	of	high‐resolution	melting	(HRM)	 
assay	3	using	a	randomly	chosen	subset	of	9	cultured	samples	and	7	clinical	specimens











Tm SD CV% Intra‐assay CV% Ct Tm Mean Tm SD CV% Intra‐assay CV% Mean Tm SD CV% Inter‐assay CV%
M. microti ATCC	
19422
 26.37 86.83     28.03 86.83     28.56 86.83     86.83 0.00 0.00  
M. 
tuberculosis
H37RV  29.35 86.82     29.36 86.82     29.03 86.85     86.83 0.02 0.02  
M. bovis 
isolate
20593 Cow 35.04 86.88 86.86 0.02 0.02  33.95 86.85 86.85 0.00 0.00  33.73 86.87 86.90 0.03 0.03  86.87 0.02 0.03  
35.10 86.85     33.59 86.85     33.52 86.92         
35.36 86.85     33.70 86.85     32.61 86.90         
M. bovis 
isolate
20594 Cow 32.92 86.85 86.85 0.00 0.00  32.73 86.85 86.86 0.02 0.02  32.36 86.83 86.88 0.05 0.05  86.86 0.02 0.02  
33.48 86.85     32.56 86.85     32.62 86.90         
33.28 86.85     32.83 86.88     32.60 86.92         
M. bovis 
isolate
20609 Cow 35.18 86.83 86.83 0.02 0.02  34.71 86.87 86.87 0.03 0.03  33.73 86.90 86.87 0.06 0.07  86.86 0.02 0.02  
34.74 86.85     33.89 86.85     33.87 86.80         
34.54 86.82     34.39 86.90     33.60 86.90         
M. bovis 
isolate
20608 Cow 28.92 86.82 86.82 0.01 0.01  28.69 86.83 86.84 0.01 0.01  27.96 86.78 86.77 0.04 0.04  86.81 0.04 0.04  
28.55 86.83     28.50 86.85     28.36 86.73         
29.49 86.82     28.75 86.85     28.46 86.80         
(Continues)
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CV% Ct Tm Mean Tm SD CV% Intra‐assay CV% Mean Tm SD CV% Inter‐assay CV%
M. bovis 22539 Cow 21.42 82.73 82.76 0.04 0.04 0.04 21.80 82.92 82.92 0.00 0.00 0.04 20.49 82.77 82.76 0.01 0.01 0.02 82.81 0.09 0.11 0.14
21.55 82.75     21.44 82.92     20.44 82.75         
21.38 82.80     21.60 82.92     20.52 82.75         
M. microti 22928 Cat 16.90 83.17 83.17 0.02 0.02  17.13 83.40 83.42 0.02 0.02  16.01 83.30 83.31 0.01 0.01  83.30 0.13 0.15  
16.93 83.18     17.13 83.43     15.89 83.30         
17.01 83.15     17.08 83.43     16.13 83.32         
M. microti 15‐1765 Cat 21.77 83.18 83.16 0.03 0.03  22.21 83.32 83.30 0.02 0.02  20.79 83.28 83.28 0.02 0.02  83.25 0.08 0.09  
21.44 83.17     21.93 83.30     19.99 83.27         
21.78 83.13     22.05 83.28     20.59 83.30         
M. microti 14‐58 Cat 24.40 83.02 83.02 0.01 0.01  24.39 83.28 83.27 0.02 0.02  23.44 83.28 83.28 0.02 0.02  83.19 0.15 0.18  
24.39 83.02     24.64 83.28     23.18 83.30         
24.31 83.03     24.43 83.25     23.45 83.27         
M. microti 14‐690 Alpaca 15.10 83.05 83.05 0.03 0.03  15.33 83.30 83.29 0.01 0.01  14.28 83.30 83.29 0.01 0.01  83.21 0.14 0.17  
15.13 83.07     15.27 83.28     14.20 83.30         
15.21 83.02     15.29 83.30     14.24 83.28         
M. microti 16‐2156 Cat 23.07 83.07 83.08 0.02 0.02  23.48 83.30 83.31 0.01 0.01  22.32 83.27 83.27 0.00 0.00  83.22 0.12 0.14  
23.49 83.08     23.60 83.30     22.17 83.27         
23.49 83.10     23.57 83.32     22.01 83.27         
M. microti 1522744 Cat 22.79 83.12 83.09 0.03 0.03  22.89 83.33 83.29 0.03 0.04  21.82 83.27 83.26 0.01 0.01  83.21 0.11 0.13  
22.67 83.07     22.97 83.27     21.74 83.27         
22.68 83.08     22.94 83.27     21.49 83.25         
M. microti 16‐1347 Cat 18.92 83.13 83.15 0.03 0.03 0.02 19.20 83.30 83.27 0.03 0.03 0.02 17.52 83.30 83.30 0.00 0.00 0.01 83.24 0.08 0.10 0.14
18.94 83.13     18.99 83.25     17.21 83.30         
18.87 83.18     18.86 83.25     17.32 83.30         
TA B L E  A 3   (Continued)
TA B L E  A 4  Raw	data	set	and	statistical	parameters	generated	from	the	intra‐	and	interassay	variability	of	high‐resolution	melting	(HRM)	 
assay	3	using	a	randomly	chosen	subset	of	9	cultured	samples	and	7	clinical	specimens











Tm SD CV% Intra‐assay CV% Ct Tm Mean Tm SD CV% Intra‐assay CV% Mean Tm SD CV% Inter‐assay CV%
M. microti ATCC	
19422
 26.37 86.83     28.03 86.83     28.56 86.83     86.83 0.00 0.00  
M. 
tuberculosis
H37RV  29.35 86.82     29.36 86.82     29.03 86.85     86.83 0.02 0.02  
M. bovis 
isolate
20593 Cow 35.04 86.88 86.86 0.02 0.02  33.95 86.85 86.85 0.00 0.00  33.73 86.87 86.90 0.03 0.03  86.87 0.02 0.03  
35.10 86.85     33.59 86.85     33.52 86.92         
35.36 86.85     33.70 86.85     32.61 86.90         
M. bovis 
isolate
20594 Cow 32.92 86.85 86.85 0.00 0.00  32.73 86.85 86.86 0.02 0.02  32.36 86.83 86.88 0.05 0.05  86.86 0.02 0.02  
33.48 86.85     32.56 86.85     32.62 86.90         
33.28 86.85     32.83 86.88     32.60 86.92         
M. bovis 
isolate
20609 Cow 35.18 86.83 86.83 0.02 0.02  34.71 86.87 86.87 0.03 0.03  33.73 86.90 86.87 0.06 0.07  86.86 0.02 0.02  
34.74 86.85     33.89 86.85     33.87 86.80         
34.54 86.82     34.39 86.90     33.60 86.90         
M. bovis 
isolate
20608 Cow 28.92 86.82 86.82 0.01 0.01  28.69 86.83 86.84 0.01 0.01  27.96 86.78 86.77 0.04 0.04  86.81 0.04 0.04  
28.55 86.83     28.50 86.85     28.36 86.73         
29.49 86.82     28.75 86.85     28.46 86.80         
(Continues)
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Tm SD CV% Intra‐assay CV% Ct Tm Mean Tm SD CV% Intra‐assay CV% Mean Tm SD CV% Inter‐assay CV%
M. bovis 
isolate
20596 Cow 29.93 86.78 86.79 0.01 0.01  29.35 86.83 86.84 0.01 0.01  29.37 86.80 86.80 0.00 0.00  86.81 0.02 0.03  
29.69 86.80     29.25 86.85     28.64 86.80         
29.87 86.80     29.30 86.83     28.92 86.80         
M. bovis 
isolate
20600 Cow 27.83 86.83 86.83 0.00 0.00  29.51 86.85 86.83 0.02 0.02  29.82 86.85 86.84 0.01 0.01  86.84 0.01 0.01  
29.66 86.83     30.07 86.83     29.91 86.83         
30.09 86.83     30.49 86.82     29.91 86.85         
M. bovis 
isolate
20606 Cow 28.36 86.80 86.81 0.02 0.02 0.01 27.94 86.80 86.78 0.03 0.03 0.02 27.42 86.83 86.84 0.01 0.01 0.03 86.81 0.03 0.03 0.03
27.86 86.80     28.01 86.78     27.34 86.85         
28.12 86.83     27.88 86.75     27.47 86.83         
M. bovis 
specimen
20593 Cow 19.04 86.83 86.84 0.01 0.01  18.82 86.82 86.80 0.02 0.02  18.64 86.88 86.92 0.04 0.04  86.85 0.06 0.07  
18.84 86.85     19.19 86.80     18.80 86.92         
18.65 86.85     18.95 86.78     18.68 86.95         
M. bovis 
specimen
20594 Cow 36.86  86.88 0.01 0.01  16.22 86.78 86.78 0.02 0.02  16.16 86.90 86.91 0.01 0.01  86.86 0.06 0.07  
16.18 86.88     16.51 86.80     16.18 86.92         
16.75 86.87     16.55 86.77     16.07 86.90         
M. bovis 
specimen
20609 Cow 29.46 86.85 86.85 0.00 0.00  28.99 86.80 86.82 0.03 0.03  28.66 86.88 86.85 0.03 0.03  86.84 0.02 0.02  
29.75 86.85     29.35 86.80     28.51 86.85         
29.04 86.85     29.45 86.85     28.57 86.83         
M. bovis 
specimen
20608 Cow 17.18 86.85 86.88 0.03 0.03  17.34 86.85 86.86 0.01 0.01  17.03 86.90 86.88 0.03 0.03  86.87 0.01 0.02  
17.43 86.90     17.60 86.85     17.13 86.90         
17.14 86.88     17.64 86.87     17.22 86.85         
M. bovis 
specimen
20596 Cow 16.60 86.85 86.86 0.04 0.05  16.99 86.90 86.90 0.00 0.00  16.66 86.87 86.86 0.01 0.01  86.87 0.03 0.03  
17.02 86.90     17.01 86.90     16.54 86.85         
16.84 86.82     17.14 86.90     16.42 86.85         
M. bovis 
specimen
20600 Cow 16.88 86.85 86.85 0.00 0.00  17.15 86.88 86.88 0.03 0.03  16.97 86.85 86.84 0.01 0.01  86.86 0.02 0.02  
16.83 86.85     17.47 86.90     16.96 86.85         
16.74 86.85     17.24 86.85     16.64 86.83         
M. bovis 
specimen
20606 Cow 17.22 86.85 86.85 0.00 0.00 0.01 17.18 86.85 86.85 0.02 0.02 0.02 16.72 86.85 86.83 0.03 0.03 0.02 86.84 0.01 0.02 0.04
17.34 86.85     17.31 86.83     16.77 86.80         






 30.43 86.40 86.37 0.04 0.04  30.70 86.40 86.40 0.02 0.02  30.26 86.43 86.44 0.01 0.01  86.40 0.04 0.04  
30.84 86.38     30.51 86.38     30.14 86.45         






 30.62 86.45 86.44 0.02 0.02 0.03 31.32 86.42 86.41 0.03 0.03 0.03 30.56 86.47 86.46 0.03 0.04 0.03 86.44 0.02 0.03 0.04
30.72 86.42     31.15 86.38     30.23 86.42         
30.78 86.45     31.14 86.43     30.27 86.48         
TA B L E  A 4   (Continued)
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Tm SD CV% Intra‐assay CV% Ct Tm Mean Tm SD CV% Intra‐assay CV% Mean Tm SD CV% Inter‐assay CV%
M. bovis 
isolate
20596 Cow 29.93 86.78 86.79 0.01 0.01  29.35 86.83 86.84 0.01 0.01  29.37 86.80 86.80 0.00 0.00  86.81 0.02 0.03  
29.69 86.80     29.25 86.85     28.64 86.80         
29.87 86.80     29.30 86.83     28.92 86.80         
M. bovis 
isolate
20600 Cow 27.83 86.83 86.83 0.00 0.00  29.51 86.85 86.83 0.02 0.02  29.82 86.85 86.84 0.01 0.01  86.84 0.01 0.01  
29.66 86.83     30.07 86.83     29.91 86.83         
30.09 86.83     30.49 86.82     29.91 86.85         
M. bovis 
isolate
20606 Cow 28.36 86.80 86.81 0.02 0.02 0.01 27.94 86.80 86.78 0.03 0.03 0.02 27.42 86.83 86.84 0.01 0.01 0.03 86.81 0.03 0.03 0.03
27.86 86.80     28.01 86.78     27.34 86.85         
28.12 86.83     27.88 86.75     27.47 86.83         
M. bovis 
specimen
20593 Cow 19.04 86.83 86.84 0.01 0.01  18.82 86.82 86.80 0.02 0.02  18.64 86.88 86.92 0.04 0.04  86.85 0.06 0.07  
18.84 86.85     19.19 86.80     18.80 86.92         
18.65 86.85     18.95 86.78     18.68 86.95         
M. bovis 
specimen
20594 Cow 36.86  86.88 0.01 0.01  16.22 86.78 86.78 0.02 0.02  16.16 86.90 86.91 0.01 0.01  86.86 0.06 0.07  
16.18 86.88     16.51 86.80     16.18 86.92         
16.75 86.87     16.55 86.77     16.07 86.90         
M. bovis 
specimen
20609 Cow 29.46 86.85 86.85 0.00 0.00  28.99 86.80 86.82 0.03 0.03  28.66 86.88 86.85 0.03 0.03  86.84 0.02 0.02  
29.75 86.85     29.35 86.80     28.51 86.85         
29.04 86.85     29.45 86.85     28.57 86.83         
M. bovis 
specimen
20608 Cow 17.18 86.85 86.88 0.03 0.03  17.34 86.85 86.86 0.01 0.01  17.03 86.90 86.88 0.03 0.03  86.87 0.01 0.02  
17.43 86.90     17.60 86.85     17.13 86.90         
17.14 86.88     17.64 86.87     17.22 86.85         
M. bovis 
specimen
20596 Cow 16.60 86.85 86.86 0.04 0.05  16.99 86.90 86.90 0.00 0.00  16.66 86.87 86.86 0.01 0.01  86.87 0.03 0.03  
17.02 86.90     17.01 86.90     16.54 86.85         
16.84 86.82     17.14 86.90     16.42 86.85         
M. bovis 
specimen
20600 Cow 16.88 86.85 86.85 0.00 0.00  17.15 86.88 86.88 0.03 0.03  16.97 86.85 86.84 0.01 0.01  86.86 0.02 0.02  
16.83 86.85     17.47 86.90     16.96 86.85         
16.74 86.85     17.24 86.85     16.64 86.83         
M. bovis 
specimen
20606 Cow 17.22 86.85 86.85 0.00 0.00 0.01 17.18 86.85 86.85 0.02 0.02 0.02 16.72 86.85 86.83 0.03 0.03 0.02 86.84 0.01 0.02 0.04
17.34 86.85     17.31 86.83     16.77 86.80         






 30.43 86.40 86.37 0.04 0.04  30.70 86.40 86.40 0.02 0.02  30.26 86.43 86.44 0.01 0.01  86.40 0.04 0.04  
30.84 86.38     30.51 86.38     30.14 86.45         






 30.62 86.45 86.44 0.02 0.02 0.03 31.32 86.42 86.41 0.03 0.03 0.03 30.56 86.47 86.46 0.03 0.04 0.03 86.44 0.02 0.03 0.04
30.72 86.42     31.15 86.38     30.23 86.42         
30.78 86.45     31.14 86.43     30.27 86.48         
TA B L E  A 4   (Continued)
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TA B L E  A 5  Raw	data	set	and	statistical	parameters	generated	from	the	intra‐	and	interassay	variability	of	high‐resolution	melting	 
(HRM)	assay	2	using	a	randomly	chosen	subset	of	18	clinical	specimens














CV% Ct Tm Mean Tm SD CV%
Intra‐assay 
CV% Mean Tm SD CV% Inter‐assay CV%
M. microti ATCC	
19422






 25.78 82.82     25.33 82.73     25.23 82.62     82.72 0.10 0.12  
M. tuber-
culosis





Elephant 29.98 83.58 83.59 0.01 0.01  29.48 83.50 83.53 0.03 0.03  29.16 83.47 83.44 0.02 0.03  83.52 0.08 0.09  
29.90 83.60     29.72 83.55     29.33 83.43         





Elephant 24.51 83.77 83.81 0.03 0.04 0.03 24.78 83.68 83.68 0.03 0.03 0.03 24.44 83.60 83.57 0.03 0.03 0.03 83.68 0.12 0.14 0.12
24.84 83.82     24.64 83.70     24.49 83.55         
24.63 83.83     24.78 83.65     24.78 83.55         
Microsoft. 
caprae
22971 Cow 31.58 83.20 83.22 0.02 0.02  31.45 83.13 83.13 0.02 0.02  31.21 83.08 82.99 0.08 0.09  83.11 0.11 0.14  
31.37 83.23     30.75 83.12     31.27 82.95         
31.39 83.22     30.96 83.15     31.04 82.95         
M. caprae 22914 Cow 29.37 83.17 83.16 0.01 0.01  28.86 83.00 83.02 0.03 0.03  28.57 82.88 82.88 0.02 0.02  83.02 0.14 0.17  
29.04 83.15     28.59 83.05     28.93 82.87         
28.91 83.17     28.54 83.00     28.40 82.90         
M. caprae 22848 Cow 19.00 83.35 83.34 0.04 0.04  19.60 83.25 83.26 0.01 0.01  19.69 83.08 83.07 0.01 0.01  83.22 0.14 0.16  
19.33 83.37     19.27 83.27     19.58 83.07         
19.85 83.30     19.16 83.25     19.57 83.07         
M. caprae 13‐162 Cow 32.47 83.10 83.11 0.02 0.02 0.02 31.56 82.98 82.98 0.03 0.03 0.02 31.10 82.87 82.87 0.02 0.02 0.03 82.98 0.12 0.15 0.15
33.03 83.10     31.89 82.95     32.23 82.85         
31.85 83.13     31.93 83.00     31.75 82.88         
M. bovis 20593 Cow 14.57 82.90 82.98 0.07 0.08  14.31 82.80 82.79 0.01 0.01  14.18 82.68 82.69 0.01 0.01  82.82 0.15 0.18  
14.67 83.02     14.32 82.80     14.27 82.70         
14.58 83.02     14.23 82.78     14.81 82.70         
M. bovis 20594 Cow 12.65 83.07 83.02 0.04 0.05  12.54 82.85 82.85 0.03 0.03  11.91 82.80 82.78 0.02 0.02  82.89 0.12 0.15  
12.60 83.00     12.86 82.83     11.48 82.77         
12.49 83.00     12.58 82.88     11.69 82.77         
M. bovis 20609 Cow 22.46 82.87 82.89 0.03 0.04  22.84 82.78 82.76 0.02 0.02  22.50 82.65 82.63 0.03 0.03  82.76 0.13 0.16  
22.49 82.93     22.65 82.75     22.62 82.65         
22.29 82.88     22.45 82.75     22.55 82.60         
M. bovis 20608 Cow 13.54 83.03 83.03 0.02 0.02  13.30 82.85 82.84 0.01 0.01  13.11 82.68 82.70 0.02 0.02  82.86 0.17 0.20  
13.19 83.02     13.46 82.85     13.29 82.72         
13.31 83.05     13.16 82.83     13.13 82.70         
M. bovis 20596 Cow 12.86 83.02 83.05 0.03 0.03  12.81 82.83 82.83 0.00 0.00  13.02 82.65 82.68 0.04 0.04  82.85 0.18 0.22  
12.93 83.05     12.82 82.83     12.97 82.68         
13.10 83.07     12.84 82.83     12.99 82.72         
M. bovis 20600 Cow 13.19 83.00 83.00 0.00 0.00 0.04 12.90 82.82 82.83 0.02 0.02 0.02 13.18 82.65 82.66 0.04 0.05 0.03 82.83 0.17 0.21 0.19
13.17 83.00     13.08 82.82     12.77 82.62         
13.07 83.00     13.06 82.85     12.95 82.70         
(Continues)
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TA B L E  A 5  Raw	data	set	and	statistical	parameters	generated	from	the	intra‐	and	interassay	variability	of	high‐resolution	melting	 
(HRM)	assay	2	using	a	randomly	chosen	subset	of	18	clinical	specimens














CV% Ct Tm Mean Tm SD CV%
Intra‐assay 
CV% Mean Tm SD CV% Inter‐assay CV%
M. microti ATCC	
19422






 25.78 82.82     25.33 82.73     25.23 82.62     82.72 0.10 0.12  
M. tuber-
culosis





Elephant 29.98 83.58 83.59 0.01 0.01  29.48 83.50 83.53 0.03 0.03  29.16 83.47 83.44 0.02 0.03  83.52 0.08 0.09  
29.90 83.60     29.72 83.55     29.33 83.43         





Elephant 24.51 83.77 83.81 0.03 0.04 0.03 24.78 83.68 83.68 0.03 0.03 0.03 24.44 83.60 83.57 0.03 0.03 0.03 83.68 0.12 0.14 0.12
24.84 83.82     24.64 83.70     24.49 83.55         
24.63 83.83     24.78 83.65     24.78 83.55         
Microsoft. 
caprae
22971 Cow 31.58 83.20 83.22 0.02 0.02  31.45 83.13 83.13 0.02 0.02  31.21 83.08 82.99 0.08 0.09  83.11 0.11 0.14  
31.37 83.23     30.75 83.12     31.27 82.95         
31.39 83.22     30.96 83.15     31.04 82.95         
M. caprae 22914 Cow 29.37 83.17 83.16 0.01 0.01  28.86 83.00 83.02 0.03 0.03  28.57 82.88 82.88 0.02 0.02  83.02 0.14 0.17  
29.04 83.15     28.59 83.05     28.93 82.87         
28.91 83.17     28.54 83.00     28.40 82.90         
M. caprae 22848 Cow 19.00 83.35 83.34 0.04 0.04  19.60 83.25 83.26 0.01 0.01  19.69 83.08 83.07 0.01 0.01  83.22 0.14 0.16  
19.33 83.37     19.27 83.27     19.58 83.07         
19.85 83.30     19.16 83.25     19.57 83.07         
M. caprae 13‐162 Cow 32.47 83.10 83.11 0.02 0.02 0.02 31.56 82.98 82.98 0.03 0.03 0.02 31.10 82.87 82.87 0.02 0.02 0.03 82.98 0.12 0.15 0.15
33.03 83.10     31.89 82.95     32.23 82.85         
31.85 83.13     31.93 83.00     31.75 82.88         
M. bovis 20593 Cow 14.57 82.90 82.98 0.07 0.08  14.31 82.80 82.79 0.01 0.01  14.18 82.68 82.69 0.01 0.01  82.82 0.15 0.18  
14.67 83.02     14.32 82.80     14.27 82.70         
14.58 83.02     14.23 82.78     14.81 82.70         
M. bovis 20594 Cow 12.65 83.07 83.02 0.04 0.05  12.54 82.85 82.85 0.03 0.03  11.91 82.80 82.78 0.02 0.02  82.89 0.12 0.15  
12.60 83.00     12.86 82.83     11.48 82.77         
12.49 83.00     12.58 82.88     11.69 82.77         
M. bovis 20609 Cow 22.46 82.87 82.89 0.03 0.04  22.84 82.78 82.76 0.02 0.02  22.50 82.65 82.63 0.03 0.03  82.76 0.13 0.16  
22.49 82.93     22.65 82.75     22.62 82.65         
22.29 82.88     22.45 82.75     22.55 82.60         
M. bovis 20608 Cow 13.54 83.03 83.03 0.02 0.02  13.30 82.85 82.84 0.01 0.01  13.11 82.68 82.70 0.02 0.02  82.86 0.17 0.20  
13.19 83.02     13.46 82.85     13.29 82.72         
13.31 83.05     13.16 82.83     13.13 82.70         
M. bovis 20596 Cow 12.86 83.02 83.05 0.03 0.03  12.81 82.83 82.83 0.00 0.00  13.02 82.65 82.68 0.04 0.04  82.85 0.18 0.22  
12.93 83.05     12.82 82.83     12.97 82.68         
13.10 83.07     12.84 82.83     12.99 82.72         
M. bovis 20600 Cow 13.19 83.00 83.00 0.00 0.00 0.04 12.90 82.82 82.83 0.02 0.02 0.02 13.18 82.65 82.66 0.04 0.05 0.03 82.83 0.17 0.21 0.19
13.17 83.00     13.08 82.82     12.77 82.62         
13.07 83.00     13.06 82.85     12.95 82.70         
(Continues)
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CV% Ct Tm Mean Tm SD CV%
Intra‐assay 
CV% Mean Tm SD CV% Inter‐assay CV%
M. microti 22928 Cat 21.04 83.28 83.32 0.04 0.04  21.00 83.22 83.22 0.01 0.01  20.82 83.03 83.04 0.01 0.01  83.20 0.14 0.17  
21.25 83.33     21.16 83.22     20.88 83.05         
21.00 83.35     20.93 83.23     20.82 83.05         
M. microti 15‐342 Alpaca 15.26 83.35 83.36 0.01 0.01  14.98 83.27 83.24 0.02 0.03  15.10 83.03 83.06 0.02 0.03  83.22 0.15 0.18  
15.15 83.35     14.60 83.23     14.91 83.07         
15.19 83.37     15.04 83.23     15.15 83.07         
M. microti 17‐1084 Cat 22.93 83.27 83.29 0.02 0.02  22.99 83.20 83.19 0.02 0.02  23.08 83.05 83.07 0.03 0.03  83.18 0.11 0.13  
22.82 83.30     22.95 83.20     22.87 83.05         
22.90 83.30     23.20 83.17     23.15 83.10         
M. microti 15‐1955 Cat 25.48 83.23 83.23 0.02 0.02  25.79 83.10 83.12 0.04 0.05  26.19 83.00 82.99 0.04 0.04  83.12 0.12 0.15  
25.21 83.22     25.61 83.10     25.74 82.95         
25.37 83.25     25.65 83.17     26.35 83.02         
M. microti 14‐690 Alpaca 20.03 83.32 83.32 0.00 0.00  20.00 83.20 83.22 0.02 0.02  20.13 83.05 83.03 0.03 0.03  83.19 0.15 0.17  
19.84 83.32     19.90 83.23     19.94 83.05         
19.90 83.32     20.01 83.23     19.98 83.00         
M. microti 17‐549 Llama 30.79 83.22 83.23 0.04 0.05 0.02 30.07 83.10 83.13 0.03 0.03 0.03 30.24 82.90 82.96 0.05 0.06 0.04 83.11 0.14 0.17 0.16
30.23 83.20     30.62 83.15     30.03 83.00         
30.78 83.28     30.20 83.13     29.89 82.98         
TA B L E  A 5   (Continued)
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CV% Ct Tm Mean Tm SD CV%
Intra‐assay 
CV% Mean Tm SD CV% Inter‐assay CV%
M. microti 22928 Cat 21.04 83.28 83.32 0.04 0.04  21.00 83.22 83.22 0.01 0.01  20.82 83.03 83.04 0.01 0.01  83.20 0.14 0.17  
21.25 83.33     21.16 83.22     20.88 83.05         
21.00 83.35     20.93 83.23     20.82 83.05         
M. microti 15‐342 Alpaca 15.26 83.35 83.36 0.01 0.01  14.98 83.27 83.24 0.02 0.03  15.10 83.03 83.06 0.02 0.03  83.22 0.15 0.18  
15.15 83.35     14.60 83.23     14.91 83.07         
15.19 83.37     15.04 83.23     15.15 83.07         
M. microti 17‐1084 Cat 22.93 83.27 83.29 0.02 0.02  22.99 83.20 83.19 0.02 0.02  23.08 83.05 83.07 0.03 0.03  83.18 0.11 0.13  
22.82 83.30     22.95 83.20     22.87 83.05         
22.90 83.30     23.20 83.17     23.15 83.10         
M. microti 15‐1955 Cat 25.48 83.23 83.23 0.02 0.02  25.79 83.10 83.12 0.04 0.05  26.19 83.00 82.99 0.04 0.04  83.12 0.12 0.15  
25.21 83.22     25.61 83.10     25.74 82.95         
25.37 83.25     25.65 83.17     26.35 83.02         
M. microti 14‐690 Alpaca 20.03 83.32 83.32 0.00 0.00  20.00 83.20 83.22 0.02 0.02  20.13 83.05 83.03 0.03 0.03  83.19 0.15 0.17  
19.84 83.32     19.90 83.23     19.94 83.05         
19.90 83.32     20.01 83.23     19.98 83.00         
M. microti 17‐549 Llama 30.79 83.22 83.23 0.04 0.05 0.02 30.07 83.10 83.13 0.03 0.03 0.03 30.24 82.90 82.96 0.05 0.06 0.04 83.11 0.14 0.17 0.16
30.23 83.20     30.62 83.15     30.03 83.00         
30.78 83.28     30.20 83.13     29.89 82.98         
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F I G U R E  A 2  qPCR	amplification	curves	and	standard	curves	of	the	serial	dilution	using	(a)	M. bovis	BCG	Pasteur	ATCC	35734	and	(b)	
M. bovis	for	high‐resolution	melting	(HRM)	assay	3
(a)
(b)
